ACB
Price
$5.56
Change
+$0.19 (+3.54%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
238.86M
14 days until earnings call
AKAN
Price
$1.44
Change
+$0.18 (+14.29%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
1.25M
Interact to see
Advertisement

ACB vs AKAN

Header iconACB vs AKAN Comparison
Open Charts ACB vs AKANBanner chart's image
Aurora Cannabis
Price$5.56
Change+$0.19 (+3.54%)
Volume$2.53K
Capitalization238.86M
Akanda
Price$1.44
Change+$0.18 (+14.29%)
Volume$929
Capitalization1.25M
ACB vs AKAN Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. AKAN commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Buy and AKAN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ACB: $5.57 vs. AKAN: $1.44)
Brand notoriety: ACB: Notable vs. AKAN: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 67% vs. AKAN: 322%
Market capitalization -- ACB: $238.86M vs. AKAN: $1.25M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. AKAN’s [@Pharmaceuticals: Other] market capitalization is $1.25M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileAKAN’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • AKAN’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than AKAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish while AKAN’s TA Score has 4 bullish TA indicator(s).

  • ACB’s TA Score: 4 bullish, 5 bearish.
  • AKAN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, AKAN is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +0.91% price change this week, while AKAN (@Pharmaceuticals: Other) price change was +19.01% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +73.69%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +62.67%.

Reported Earning Dates

ACB is expected to report earnings on Aug 07, 2025.

AKAN is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+73.69% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than AKAN($1.25M). ACB YTD gains are higher at: 31.059 vs. AKAN (-21.500). AKAN has higher annual earnings (EBITDA): -3.86M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. AKAN (3.93M). AKAN has less debt than ACB: AKAN (3.83M) vs ACB (103M). ACB has higher revenues than AKAN: ACB (212M) vs AKAN (111K).
ACBAKANACB / AKAN
Capitalization239M1.25M19,059%
EBITDA-1.64B-3.86M42,406%
Gain YTD31.059-21.500-144%
P/E RatioN/AN/A-
Revenue212M111K190,991%
Total Cash149M3.93M3,790%
Total Debt103M3.83M2,687%
FUNDAMENTALS RATINGS
ACB: Fundamental Ratings
ACB
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACBAKAN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCEL5.630.69
+13.97%
FuelCell Energy Inc
GOCO5.950.16
+2.76%
GoHealth
HSIC70.571.01
+1.45%
Henry Schein
TCBIO19.940.14
+0.71%
Texas Capital Bancshares
TR35.530.10
+0.28%
Tootsie Roll Industries Inc

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and SCYX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+6.44%
SCYX - AKAN
26%
Poorly correlated
-0.65%
SNOA - AKAN
25%
Poorly correlated
+4.11%
ACB - AKAN
24%
Poorly correlated
+3.07%
SNDL - AKAN
24%
Poorly correlated
+0.79%
TLRY - AKAN
23%
Poorly correlated
-1.65%
More